Details for New Drug Application (NDA): 202436
✉ Email this page to a colleague
The generic ingredient in TRANEXAMIC ACID is tranexamic acid. There are eight drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the tranexamic acid profile page.
Summary for 202436
Tradename: | TRANEXAMIC ACID |
Applicant: | Heritage |
Ingredient: | tranexamic acid |
Patents: | 0 |
Pharmacology for NDA: 202436
Physiological Effect | Decreased Fibrinolysis |
Medical Subject Heading (MeSH) Categories for 202436
Suppliers and Packaging for NDA: 202436
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
TRANEXAMIC ACID | tranexamic acid | INJECTABLE;INJECTION | 202436 | ANDA | Methapharm, Inc. | 67850-041 | 67850-041-10 | 10 VIAL, SINGLE-USE in 1 CARTON (67850-041-10) / 10 mL in 1 VIAL, SINGLE-USE (67850-041-00) |
TRANEXAMIC ACID | tranexamic acid | INJECTABLE;INJECTION | 202436 | ANDA | Methapharm, Inc. | 67850-042 | 67850-042-10 | 10 AMPULE in 1 CARTON (67850-042-10) / 10 mL in 1 AMPULE (67850-042-00) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 100MG/ML | ||||
Approval Date: | Feb 11, 2014 | TE: | AP | RLD: | No |
Complete Access Available with Subscription